Company Filing History:
Years Active: 2023-2025
Title: Innovations in Cancer Therapy by Ann F Cheung
Introduction
Ann F Cheung is a prominent inventor based in Lincoln, MA (US), known for her significant contributions to cancer therapy. With a total of 13 patents to her name, she has been at the forefront of developing innovative treatments that target cancer cells effectively.
Latest Patents
Her latest patents include multi-specific binding proteins that bind to B-cell maturation antigen (BCMA), NKG2D, and CD16. These proteins are designed to kill human cancer cells and are accompanied by pharmaceutical compositions and therapeutic methods useful for cancer treatment. The multi-specific binding proteins exhibit high potency and maximum lysis of target cells compared to traditional anti-BCMA monoclonal antibodies. Additionally, she has developed cancer therapy involving an anti-PD1 antibody in combination with a multi-specific binding protein that binds to a tumor-associated antigen, NKG2D receptor, and CD16. This combination therapy aims to enhance the effectiveness of cancer treatment.
Career Highlights
Ann F Cheung is currently associated with Dragonfly Therapeutics, Inc., where she continues to innovate in the field of cancer research. Her work has been instrumental in advancing therapeutic methods that improve patient outcomes.
Collaborations
Some of her notable coworkers include Asya Grinberg and William Haney, who contribute to the collaborative efforts in developing groundbreaking cancer therapies.
Conclusion
Ann F Cheung's innovative work in cancer therapy exemplifies the potential of multi-specific binding proteins in treating complex diseases. Her contributions are paving the way for more effective cancer treatments and improving the lives of patients.